Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protein Polymer Technologies was a biotechnology company that specialized in the design and production of synthetic protein polymers using recombinant DNA technology. The company's proprietary platform allowed for the creation of "protein polymers" that combined the structural properties of natural proteins like silk and elastin with specific biological functions. Their lead applications focused on medical devices and therapeutics, including surgical sealants, tissue repair matrices, and drug delivery systems. Notable products included ProLastin, a silk-elastin-like protein used for various medical applications. Despite several partnerships with major firms like 3M and Genencor, the company eventually ceased operations in the late 2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Protein Polymer Technologies.